CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Jiangsu Kanion Pharmaceutical Co., Ltd. Company Snapshot
Jiangsu Kanion Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Jiangsu Kanion Pharmaceutical Co., Ltd. with three other companies in this sector in China: Zhuzhou Qianjin Pharmaceutical Co., Ltd. (2016 sales of 2.86 billion Chinese Renmimbi [US$415.84 million] of which 54% was Medicine Manufacturing), Guangdong Taiantang Pharmaceutical Co Ltd (3.07 billion Chinese Renmimbi [US$446.36 million] ), and Harbin Gloria Pharmaceuticals Co., Ltd (2.98 billion Chinese Renmimbi [US$433.09 million] of which 77% was Pharmaceutical Manufacturing).

Sales Analysis. During the year ended December of 2016, sales at Jiangsu Kanion Pharmaceutical Co., Ltd. were 3.00 billion Chinese Renmimbi (US$435.58 million). This is an increase of 6.4% versus 2015, when the company's sales were 2.82 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Jiangsu Kanion Pharmaceutical Co., Ltd. (and since 2011, sales have increased a total of 95%). Sales of Exportation Trade saw an increase of 6.4% in 2016, from 2.82 billion Chinese Renmimbi to 3.00 billion Chinese Renmimbi. Not all segments of Jiangsu Kanion Pharmaceutical Co., Ltd. experienced an increase in sales in 2016: sales of Other Operations fell 22.6% to 2.71 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Jiangsu Kanion Pharmaceutical Co., Ltd.
  Stock Performance Chart for Jiangsu Kanion Pharmaceutical Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): 15.73
(Figures in Chinese Renmimbi)
1 Week 2.3%   13 Weeks -9.9%  
4 Weeks -8.2%   52 Weeks 11.0%  
 
Jiangsu Kanion Pharmaceutical Co., Ltd. Key Data:
  Ticker: 600557 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 3,000,277,807
(Year Ending Jan 2017).
Employees: 5,724
  Currency: Chinese Renmimbi Market Cap: 9,696,744,673
  Fiscal Yr Ends: December Shares Outstanding: 616,449,121
  Share Type: A Gu Closely Held Shares: 236,570,748
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.